Fleur Pellerin is a seasoned executive and board member currently serving on various boards, including Synapse Medicine, FINN, Crédit Mutuel Alliance Fédérale as Chairperson of the Mission Committee, and Korelya Capital as CEO. Pellerin's board memberships extend to KLM, Talan, Devialet, and Ledger, while also holding the position of President at CANNESERIES. Previous experience includes a board member role at Schneider Electric from April 2018 to May 2022. Pellerin's educational background encompasses a Doctor of Arts degree from Sookmyung Women's University, as well as degrees from ENA - Ecole nationale d'administration, Sciences Po, and ESSEC Business School.